// App-Quantinova.ai

POS0893 (2022) : FACTORS TO CONSIDER FOR MEASURING THE EFFECT OF LUNG FUNCTION ON PATIENT REPORTED OUTCOMES IN SYSTEMIC SCLEROSIS PATIENTS: ANALYSIS OF THE EUSTAR DATABASE.

Researchers

Presenter

  • M. G. Lazzaroni

Principal Investigators

  • M. Wilson

  • E. Hensor

  • J. H. W. Distler

  • G. Cuomo

  • E. Siegert

  • U. Mller-Ladner

  • Y. Allanore

  • M. J. Salvador

  • B. Anic

  • U. Walker

  • L. Czirjk

  • C. Ribi

  • C. M. Tanaseanu

  • A. Gabrielli

  • A. M. Hoffmann-Vold

  • O. Distler

  • F. Del Galdo

Medical Centers

  • ASST Spedali Civili of Brescia, University of Brescia, -, Brescia, Italy

  • University of Leeds, Leeds, United Kingdom

  • Friedrich-Alexander-U Erlangen-Nürnberg, Erlangen, Germany

  • Università della Campania, -, Napoli, Italy

  • Charite University Hospital, Berlin, Germany.

  • Justus-Liebig University, Campus Kerckhoff, -, Bad Nauheim, Germany

  • University Hospital Cochin, -, Paris, France

  • Coimbra University Hospitals, Coimbra, Portugal

  • Univeristy Hospital Centre Zagreb, Zagreb, Croatia

  • tsspital Basel, Basel, Switzerland

  • University of Pecs, Pecs, Hungary

  • Lausanne University Hospital, Lausanne, Switzerland

  • Clinical Emergency Hospital St.Pantelimon, -, Bucharest, Romania

  • Universita Politecnica delle Marche, Ancona, Italy

  • Oslo University Hospital, Oslo, Norway

  • University Hospital of Zurich, Zurich, Switzerland

Locations

  • Italy

  • United Kingdom

  • Germany

  • France

  • Portugal

  • Croatia

  • Switzerland

  • Hungary

  • Romania

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Scleroderma

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Boehringer Ingelheim

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved